Pfizer predicts $15 billion in revenue in 2021 from its COVID-19 vaccine. The pharma company expects total revenue of $59.4 billion to $61.4 billion this year. (CNBC Weekly)

The new COVID-19 variant found in Brazil has led to a resurgence of cases and deaths in the country. Public health experts are concerned more variants will threaten immunity in the future, even among people infected in the first wave. (The Atlantic)

New York Governor Andrew Cuomo announced the state will run an advertising campaign to help increase vaccination rates among Black New Yorkers. Despite Black people making up 24% of New York City’s population, they have received only 11% of vaccinations. (Reuters)

Verona’s compound ensifentrine proved to be effective in improving lung function in a Phase II trial for COPD. The win comes two years after the pharma company’s previous COPD drug nebulizer failed a Phase II trial. (Endpoints News)

Virtual care company Onduo announced it will begin providing its chronic disease management platform in Spanish. Studies have shown that inequities remain among non-English speakers when it comes to using digital health services. (STAT)